mesenchymal stem cell therapies (Osiris)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namemesenchymal stem cell therapies (Osiris)
Drug Alias NameMSC therapies (Osiris/Novartis)tissue regeneration therapies (Osiris/Novartis)mesenchymal stem cell therapies (Osiris/Novartis)OTI-050
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Osteogenic potential stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritisOsteoporosisMusculoskeletal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOsiris Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOsiris Therapeutics IncNovartis Pharmaceuticals Corp
Active IndicationsN/A
Inactive IndicationsOsteoarthritisOsteoporosisMusculoskeletal Diseases

Other Information

ATC CodeN/A
Related LinksN/A